Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian R Sloat

Showing results (21-30 of 22) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 22 results.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 30, 2011
EGFR-targeted stearoyl gemcitabine nanoparticles show enhanced anti-tumor activityMichael A Sandoval, Brian R Sloat, Dharmika S P Lansakara-P, et al.
International Journal of Pharmaceutics|March 5, 2011
In vitro and in vivo anti-tumor activities of a gemcitabine derivative carried by nanoparticlesBrian R Sloat, Michael A Sandoval, Dong Li, et al.
Pageof 3

Showing results (21-30 of 22) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 22 results.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 30, 2011
EGFR-targeted stearoyl gemcitabine nanoparticles show enhanced anti-tumor activityMichael A Sandoval, Brian R Sloat, Dharmika S P Lansakara-P, et al.
International Journal of Pharmaceutics|March 5, 2011
In vitro and in vivo anti-tumor activities of a gemcitabine derivative carried by nanoparticlesBrian R Sloat, Michael A Sandoval, Dong Li, et al.
Pageof 3